Vilon is a potent immunomodulator and anti-aging bioregulator peptide with ample research to back its benefits. There are also high levels of evidence that Vilon may help prevent/reduce the risk of cancer development and progression.
Research has shown that Vilon appears to provide better anti-aging effects when administered early in life. These findings may help open the door to better anti-aging research and help scientists to better understand how epigenetic regulation plays an important role in longevity.
